UK to pursue contract clinical trials

Article Abstract:

The UK government's proposal to offer clinical trials was to provide local biotech companies with a competitive advantage, and to put the country on the map of clinical trial providers. The idea of creating the National Clinical Trials Agency (NCTA) that is sponsored by Department of Health came after the key recommendation of Bioscience Innovation and Growth Team (BIGT) report.

United Kingdom, Clinical trials

---

Biotech as Bush bows out

Article Abstract:

The impact of the new reformed rules in the US Food and Drug Administration Amendment Act on US biotech industry, patent system and follow-on biologics is reviewed.

United States, Government domestic functions, Public affairs, Patent Owners & Lessors, Lessors of Nonfinancial Intangible Assets (except Copyrighted Works), Patent owners and lessors, Political activity, Bush, George W., Patent licenses, Patent licensing, United States. Food and Drug Administration, Health policy, Patent licencing

---

Similar abstracts:

• Abstracts: Industry ponders reimbursement crisis. McClellan moves on, sets sights on drug reimbursement. New rules for US drug reimbursement
• Abstracts: Insect resistance management in GM crops: Past, present and future. Transgenic plants expressing two Bacillus thuringiensis toxins delay insect resistance evolution
• Abstracts: Building a strategy for maximizing intellectual property value. The patent gamble: strategic insights for playing the worldwide patent game
• Abstracts: Acquisition signals shift from US market. UK urged to plug "bioprocessing gap"
• Abstracts: Monsanto unaffected by merger halt? California votes for embryonic stem cell research. FDA panel recommends easing gene therapy trial limits

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.